|
|
Article: Study Shows Paxil CR(TM) Is Effective and Generally Well-Tolerated For Patients With Social Anxiety Disorder; Paxil CR, the First and Only Controlled-Release SSRI Approved for Social Anxiety Disorder, Demonstrated a Low Rate of Patient Dropouts in the Study.
- Article from:
- PR Newswire
- Article date:
- February 17, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
GlaxoSmithKline's Paxil CR(TM) (paroxetine HCl) Controlled-Release Tablets is a generally well-tolerated treatment for social anxiety disorder, according to a study published in the February issue of the Journal of Clinical Psychiatry. In the study, approximately three times as many patients taking Paxil CR achieved remission compared to placebo. In addition, dropout rates due to adverse events such as sexual dysfunction were low and comparable for both treatment groups. These findings are important since discontinuation of treatment is a well-recognized issue in managing social anxiety disorder.
Recently approved for the treatment of social anxiety disorder, ...